Addex Therapeutics
ADXN
3 hedge funds and large institutions have $2.94M invested in Addex Therapeutics in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
18% less capital invested
Capital invested by funds: $3.57M → $2.94M (-$627K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$130K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Caxton Corporation
Princeton,
New Jersey
| $2.79M | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $121K | +$130K | +580 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $26K | +$27.1K | +121 | +2,420% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$1K | -2 | Closed |
|
ADXN Hedge Fund Activity: Q1 2021 in Review
3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q1 2021, worth a combined $2.94M — down 18% from $3.57M a quarter earlier.
Fund positioning in ADXN was balanced in Q1 2021: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $130K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.
- 3 institutional investors held Addex Therapeutics (ADXN) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $2.94M of Addex Therapeutics stock for Q1 2021, down 18% quarter-over-quarter.
- 1 fund opened new Addex Therapeutics positions in Q1 2021 and 1 closed out, a net change of 0 holders.
- The largest Addex Therapeutics buyer in Q1 2021 was Citadel Advisors, an estimated $130K added.
- The largest Addex Therapeutics seller in Q1 2021 was Tower Research Capital (TRC), an estimated $1K sold.
Based on aggregated 13F filings for Q1 2021.